Diagnosis and Management of Neuroendocrine Carcinoma in Urology

Xiaodong WEN,Jinkai SHAO,Liqun ZHOU
DOI: https://doi.org/10.3969/j.issn.1001-1420.2011.02.018
2011-01-01
Journal of Clinical Urology
Abstract:Objective:To study the diagnosis and management of neuroendocrine carcinoma in urology.Methods: Clinical data of 24cases of neuroendocrine carcinoma in urology were reviewed.The distribution of original sites was suprarenal gland,renal plevis,urter.urinary bladder,prostate and seminal vesicle gland.Results;The pathological diagnosis was neuroendocrine carcinoma.Immunohistochemical examination showed that the tumors were stained for neuroendocrine markers such as chromogranin(CgA.16 cases).enolse(NSE.18 cases) and synaptophysin (Syn.6 cases).Tweleve patients were under follow-up as far.Tweleve patients died of this disease. Conclusions:Neuroendocrine carcinoma is a rare and aggressive tumour with a poor prognosis.Future efforts should be directed at its early detection and the development of more effective systemic therapies.
What problem does this paper attempt to address?